Guido Davidzon, MD
Clinical Assistant Professor
Boston University School of Medicine
Dept of Radiology

MD, Universidad Maimónides
MS, Massachusetts Institute of Technology

Dr. Guido A. Davidzon is a physician-scientist board certified in Nuclear Medicine. He graduated with honors from medical school in Argentina and completed an internship at Yale University New-Haven Hospital in Connecticut. He did his residency and was chief resident at Stanford Health Care. He completed a research fellowship in mitochondrial diseases at Columbia University in New York and, a U.S. National Library of Medicine Award supported, Biomedical Informatics fellowship at Massachusetts General Hospital in conjunction with a Science Masters at MIT.

Dr. Davidzon is Clinical Assistant Professor in the Department of Radiology at Stanford University and Boston University School of Medicine. His clinical specialties include early diagnostic imaging of cancer, coronary artery disease, and dementias using molecular probes as well as the treatment of cancer for which he employs targeted radiopharmaceutical therapy.

Dr. Davidzon investigates the use of machine learning in medical imaging to improve clinical outcomes, he is involved in the professional Society of Nuclear Medicine and Molecular Imaging. He serves as a peer reviewer for multiple medical journals. Dr. Davidzon is a native of Buenos Aires, Argentina and has lived in the U.S. for over a decade. He travels to Argentina frequently, with his wife and three sons.

Kaiser Permanente Santa Clara Medical Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. Author Correction: Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Sep 14; 4(1):139. PMID: 34521985
  2. Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, Halbert K, Gandhi H, He JQ, Granucci M, Johnson E, Liu DD, Uchida N, Sinha R, Chu P, Born DE, Warnock GI, Weissman I, Hayden Gephart M, Khalighi MM, Massoud TF, Iagaru A, Davidzon G, Thomas R, Nagpal S, Recht LD, Gambhir SS. A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clin Cancer Res. 2021 Sep 02. PMID: 34475101
  3. Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Aug 23; 4(1):127. PMID: 34426629
  4. Baratto L, Toriihara A, Hatami N, Aparici CM, Davidzon G, Levin CS, Iagaru A. Results of a Prospective Trial to Compare 68Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors. Diagnostics (Basel). 2021 May 30; 11(6). PMID: 34070751; PMCID: PMC8228776; DOI: 10.3390/diagnostics11060992;
  5. Fite BZ, Hinostroza V, States L, Hicks-Nelson A, Baratto L, Kallianos K, Codari M, Yu B, Jha P, Shams M, Stoyanova T, Chapelin FF, Liu A, Rashidi A, Soto F, Quintana Y, Davidzon GA, Marycz K, Gibbs IC, Chonde DB, Patel CB, Daldrup-Link HE. Increasing Diversity in Radiology and Molecular Imaging: Current Challenges. Mol Imaging Biol. 2021 Oct; 23(5):625-638. PMID: 33903986; PMCID: PMC8074707; DOI: 10.1007/s11307-021-01610-3;
  6. Eyuboglu S, Angus G, Patel BN, Pareek A, Davidzon G, Long J, Dunnmon J, Lungren MP. Multi-task weak supervision enables anatomically-resolved abnormality detection in whole-body FDG-PET/CT. Nat Commun. 2021 03 25; 12(1):1880. PMID: 33767174; PMCID: PMC7994797; DOI: 10.1038/s41467-021-22018-1;
  7. Baratto L, Song H, Duan H, Hatami N, Bagshaw H, Buyyounouski M, Hancock S, Shah SA, Srinivas S, Swift P, Moradi F, Davidzon GA, Iagaru A. PSMA- and GRPR-targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med. 2021 Mar 05. PMID: 33674398; DOI: 10.2967/jnumed.120.259630;
  8. Nakamoto R, Zaba LC, Liang T, Reddy SA, Davidzon G, Aparici CM, Nguyen J, Moradi F, Iagaru A, Franc BL. Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. J Nucl Med. 2021 Feb 05. PMID: 33547210; DOI: 10.2967/jnumed.120.254482;
  9. Nakamoto R, Harrison C, Song H, Guja KE, Hatami N, Nguyen J, Moradi F, Franc BL, Aparici CM, Davidzon G, Iagaru A. The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Mol Imaging Biol. 2021 08; 23(4):614-623. PMID: 33469884; DOI: 10.1007/s11307-021-01583-3;
  10. Chen KT, Toueg TN, Koran MEI, Davidzon G, Zeineh M, Holley D, Gandhi H, Halbert K, Boumis A, Kennedy G, Mormino E, Khalighi M, Zaharchuk G. True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation. Eur J Nucl Med Mol Imaging. 2021 07; 48(8):2416-2425. PMID: 33416955; DOI: 10.1007/s00259-020-05151-9;
Showing 10 of 55 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 55 publications over 16 distinct years, with a maximum of 11 publications in 2020 and 2021


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Nuclear Medicine
Molecular Imaging
Positron Emission Tomography
Targeted Radionuclide Therapy
Contact for Mentoring:

820 Harrison Ave
Boston MA 02118
Google Map

Davidzon's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department